Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity.
about
Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stressMineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and AtherosclerosisS-nitrosothiols and the S-nitrosoproteome of the cardiovascular systemPharmacology of Aldosterone and the Effects of Mineralocorticoid Receptor Blockade on Cardiovascular SystemsThe role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series)Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathwayUpdate on RAAS Modulation for the Treatment of Diabetic Cardiovascular DiseaseEmerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial HypertensionSIRT2 activates G6PD to enhance NADPH production and promote leukaemia cell proliferationGlutathione (GSH) and the GSH synthesis gene Gclm modulate plasma redox and vascular responses to acute diesel exhaust inhalation in miceMineralocorticoid receptor antagonists and endothelial functionAldosterone's rapid, nongenomic effects are mediated by striatin: a modulator of aldosterone's effect on estrogen action.Oxidative risk for atherothrombotic cardiovascular disease.Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator.Aldosterone receptor antagonists: effective but often forgotten.Aldosterone and inflammation.Upregulation of steroidogenic acute regulatory protein by hypoxia stimulates aldosterone synthesis in pulmonary artery endothelial cells to promote pulmonary vascular fibrosis.Glutathione peroxidase-1 modulates lipopolysaccharide-induced adhesion molecule expression in endothelial cells by altering CD14 expression.Regulation of the pentose phosphate pathway in cancerDeletion of the angiotensin II type 1 receptor-associated protein enhances renal sodium reabsorption and exacerbates angiotensin II-mediated hypertensionChronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation.A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis.pO(2)-dependent NO production determines OPPC activity in macrophages.Mineralocorticoid receptor antagonists and the metabolic syndromeSpironolactone lowers portal hypertension by inhibiting liver fibrosis, ROCK-2 activity and activating NO/PKG pathway in the bile-duct-ligated rat.Redox Pioneer: Professor Joseph Loscalzo.Endothelial cell metabolism: parallels and divergences with cancer cell metabolismHuman alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in miceAldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive miceSystems analysis of oxidant stress in the vasculatureVascular endothelial function and hypertension: insights and directionsImpact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease.Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage.Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes.Upregulation of CREM/ICER suppresses wound endothelial CRE-HIF-1α-VEGF-dependent signaling and impairs angiogenesis in type 2 diabetes.Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans.Aldosterone: a forgotten mediator of the relationship between psychological stress and heart diseaseHypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation in pulmonary artery smooth muscle cells: implication in pulmonary hypertensionHealing the orphaned heart: heart failure in a patient with glucose-6-phosphate dehydrogenase deficiency.Glutathione peroxidase-1 deficiency augments proinflammatory cytokine-induced redox signaling and human endothelial cell activation.
P2860
Q24295960-E64A77C0-398A-4A04-BC33-19CE79388FE2Q26781416-07B375D7-D2FC-46E2-A5A4-BAB1B299F394Q26852676-3A35DBE9-1653-498F-81CE-1F733F22D233Q27010641-4FF9F966-C8BF-4878-B22F-921A09DCF10FQ27013946-7F32F4F1-FC8A-4263-B9E6-F07109522C90Q27026805-DA2BDE36-0E72-4BED-9B0D-CE341A8AD7ADQ28077454-2876220E-B8AA-4F9A-930A-67F079F27990Q28085007-667C0FB9-CD1F-43CB-8519-2A21CB26F10AQ28278236-7790B611-CAFB-45E2-9015-9C42AA243337Q28391165-47C650ED-4949-4355-B81D-CFF134E9311FQ28645984-70C4F378-4EE7-402A-A202-2EE00E458636Q30410186-3A2C65B2-0647-4A11-90A8-FFBC3A57CA25Q33554184-0C261D6A-78DC-4F72-9EE7-A37B5BC9364FQ33643995-2C54255C-3D84-4A43-A4CC-72185C0B60D4Q33688485-DEFDBEAC-C233-40A9-838F-FF40DE3D6AB8Q33837784-EC0F21E4-F1C9-4757-9BC5-8F2B42339140Q33877343-E81EADAE-7D2C-4F3E-AB70-13282CE3798CQ33919459-FA4549CF-A1C7-48DA-B92A-77CD7BCA1234Q33955739-D4593783-BC5C-4D93-A23E-9EA54B147AF7Q34111828-A3484816-5FBB-43B2-AE74-16EF9E459DBBQ34117919-B8F770AB-5D3B-41DF-991B-117778520153Q34148305-1326BF3C-274E-4D78-9FD2-BB4041C6715DQ34158115-A6936D0D-E781-465A-A4EF-D16DD23F392CQ34168923-78832024-6530-45CA-A6E0-8B6E9F62302DQ34222291-4F04BBB4-6F5D-44EF-99E0-54D3CBDCC3A4Q34222592-7995F819-7ADF-40D9-91AE-F9108C72D45CQ34228247-50694558-6B42-4A1C-8202-702E3BBF83DEQ34231667-200000BA-3F2A-4C96-A957-9752136354E8Q34292918-3B2C3FA8-0115-4C24-AB88-2146B9E612A5Q34306963-E3079527-05AA-4C65-9255-ACF090BBFA6AQ34316160-F50620AF-FC01-4584-BF61-53BBD4BF32FAQ34317717-D30BFE3A-35EA-4FF6-ACC3-D1C90D498F59Q34638026-4A05D82E-D989-459A-8D95-6400CB82F38DQ34762461-452DE5F0-0E25-486E-AC26-E1CCD9359744Q34818341-86974E0A-DFE7-4135-989F-0579612A340AQ34981416-5B02BF35-0A2A-4808-A6FF-211EEC5F13D7Q34997222-76EBC719-44CD-4349-AA60-83C01D9D6774Q35115808-059F8D44-EFB4-4B2C-81C3-5D8F81D66DC8Q35203785-C5306FF7-4C6C-42A7-BDFE-EA4C92709DB4Q35372063-BF464F22-576D-4F89-AC28-AAD311DABA0A
P2860
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Aldosterone impairs vascular r ...... sphate dehydrogenase activity.
@en
type
label
Aldosterone impairs vascular r ...... sphate dehydrogenase activity.
@en
prefLabel
Aldosterone impairs vascular r ...... sphate dehydrogenase activity.
@en
P2093
P2860
P356
P1433
P1476
Aldosterone impairs vascular r ...... sphate dehydrogenase activity.
@en
P2093
Anne W Scribner
Bradley A Maron
Diane E Handy
Jane A Leopold
Robert C Stanton
Ronglih Liao
P2860
P2888
P304
P356
10.1038/NM1545
P407
P577
2007-02-04T00:00:00Z